Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Grants
  • About Akademiliv
Azar Rezapour, Eva Angenete och Ulf Yrlid. Foto: Elin Lindström.

The right treatment for rectal cancer patients through collaboration

21 June, 2023

NEW STUDY. Researchers at the University of Gothenburg and Sahlgrenska University Hospital have taken a step towards the goal of individualizing rectal cancer treatment. By analyzing tumor samples, immunologists and surgeons have jointly identified a biomarker that could offer a new way to predict which patients will benefit the most from chemoradiotherapy prior to surgery.

Rectal cancer is one of the more common forms of cancer, and the tumor is located in the lower 15 centimeters of the intestine. Most people need surgery to cure the disease. Surgery is often preceded by treatment with cytostatics and radiotherapy to shrink the tumor and reduce the risk of relapse.

The right dose for the right patient

As pretreatment can have side effects, we try to select those patients who will benefit the most from it. However, the methods that are currently available for selection are blunt. Today, imaging using MR is primarily used to determine who should receive cytostatics or radiotherapy. Trying to improve these selection methods is high on the agenda for researchers in the field worldwide. The aim is to be able to give the right dose to the right patient at the right time.

Eva Angenete. Photo: Elin Lindström.

“The outcome of our collaboration means that we have come a long way toward being able to offer customized treatment for rectal cancer in the future,” says Eva Angenete, Professor of Surgery at the Institute of Clinical Sciences and a surgeon at Sahlgrenska University Hospital. “However, we need to continue working with the marker in order to validate it in a larger population and, we hope, ultimately bring it into clinical use.”


On the computer screens you can see the multi-color microscopy images that Azar colored and which were then used to count several different cell types at the same time.

Tumor samples from 130 patients form the basis of the current study. Six potential biomarkers were then examined. One of these MxA – a footprint of the cytokine type 1 interferon – in combination with counting the number CD8+ T cells has been shown to correlate with which patients that will respond the best to pretreatment. The results have been published in the journal OncoImmunology.

Specific biomarker

Azar Rezapour. Photo: Elin Lindström.

The lead author of the article is Azar Rezapour, a doctoral student in Professor Ulf Yrlid’s group at the Institute of Biomedicine. She has carried out much of the laboratory work behind the results and has also contributed to the analyses and writing.

“I am proud that we were able to identify a specific biomarker in the tumor samples”, says Azar. “We have been able to observe that elevated levels of this biomarker correlate with high activity in the patient’s immune cells, which means that they are very likely to respond well to the treatment.”

The collaboration is now continuing to find biomarkers that can also help to identify the patients who will not respond to pre-treatment.

Ulf Yrlid. Photo: Elin Lindström.

“Our plan is to extend the immunohistological analyses with assessment of RNA expression in the same tissue,” says Ulf Yrlid, Professor of Mucosal Immunology and Microbiology at the University of Gothenburg. “By conducting a multi-analysis, we can find other properties expressed in the tumor tissue. Taken in combination with the biomarker we have now identified, this could be a method for the early identification of patients who will not respond to pretreatment.”

The collaboration is an excellent example of basic science researchers and clinical researchers working together to find answers to clinically relevant problems, known as translational research. This research approach has contributed to the high scores awarded to the University of Gothenburg and Region Västra Götaland in the Swedish Research Council’s evaluations of the national medical training and research system.

Title: A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma; OncoImmunology; https://doi.org/10.1080/2162402X.2023.2209473

BY: ELIN LINDSTRÖM

 

 

 

By: Elin Lindström
Tagged With: institutionen för biomedicin, Ny studie, vetenskaplig publicering

HAPPY SUMMER!

The newsletter from Akademiliv will return on Wednesday, August 21st.

Contact your institute to add your event to the calendar in the Staff Portal

  • Biomedicine: Kristian Kvint: kalender@biomedicine.gu.se
  • Core Facilities: Amelie Karlsson: amelie.karlsson.2@gu.se
  • Clinical Sciences: Katarina Olinder Eriksson: klinvet@gu.se
  • Medicine: Nina Raun; kommunikation@medicine.gu.se
  • Neuroscience and Physiology: Josefin Bergenholtz; kommunikation@neuro.gu.se
  • Odontology: Johan Thompson; info@odontologi.gu.se
  • Sahlgrenska Academy’s Office and faculty-wide calendar events Åsa Ekvall; info@sahlgrenska.gu.se
  • Health and Care Sciences: Karin Mossberg; vardvetenskap@fhs.gu.se

Information from Sahlgrenska Academy Research Support Office

[UPDATED JUNE 2024]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated on a monthly basis.
Current and previous newsletters are also available in the Staff Portal.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

More news

En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book

27 May, 2024

NEW BOOK. During his career as a physician specializing in internal medicine, Björn Fagerberg has been involved in many end-of-life situations, …  

She is doing her residency in the US with a medical degree from Gothenburg

21 May, 2024

STUDENT. Doing a “residency” in orthopedics in the United States is an unattainable dream for many newly qualified American doctors. Now Janina Ka …  

Alba Corell reports from a high-level brain tumor meeting

20 May, 2024

COLUMN. The recent gathering of the Scandinavian Society of Neuro-oncology (SNOG) in Gothenburg has concluded. Professor Asgeir Jakola hosted and …  

From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health

17 May, 2024

GLOBAL HEALTH. In the bustling Tygerberg University Hospital in Cape Town, a dedicated research team led by Lina Bergman, is on a mission to …  

Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024

17 May, 2024

AWARD. The Assar Gabrielsson Foundation has named Anna Wenger as the winner in the basic science research category and Sara Bjursten as the …  

A full day for PhD students focused on mental health

16 May, 2024

PHD STUDENTS. For the sixth time, PhD students at Sahlgrenska Academy were invited to PhD Day, organized by the Doctoral Student Council. The day …  

Kaj Blennow ranked highest in Sweden in neuroscience

16 May, 2024

AWARD. In this year's edition of the researcher ranking from Research.com in the field of neuroscience, Kaj Blennow is ranked 17th …  

Linda Wass is doing a postdoc at Stanford with ALF funding

14 May, 2024

ALF FUNDING. Biomedical Scientist Linda Wass has just settled in Stanford, California, where she will spend two years as a postdoc. She is the …  

Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023

14 May, 2024

AWARD. Karin Nilsson, currently a postdoc at the Department of Internal Medicine and Clinical Nutrition, receives the faculty-wide Thesis of the …  

Some answers from the proposed members of the next Faculty Board

14 May, 2024

FACULTY ELECTIONS. The eight proposed members of the next Faculty Board hereby give some brief answers on how they want to contribute to the work …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen